Search

everythinglearnresearchcommunity

for

Search:↓

Natural products in cosmetics are beneficial for skin and hair care with low toxicity.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

The Rotterdam Study aims to understand various diseases in older adults.

Planarian regeneration begins with a specific gene activation caused by injury, essential for healing and tissue regrowth.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

Lecithin organogels could be good for applying drugs to the skin because they are stable, safe, and can improve drug absorption.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

Hair loss in men is common, treatable, but not curable.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Current treatments for alopecia show no significant long-term benefits.